FORT LAUDERDALE, Fla., Sept. 23 /PRNewswire/ — OmniComm
Systems, Inc. (OTC: OMCM), one of the fastest growing companies in
the EDC marketplace, today announced that Beardsworth, a full
service contract research organization (CRO) who specializes in
difficult therapeutic areas, has selected OmniComm’s AE Reporting
System to enhance its safety reporting process. AE Reporting
is an advanced adverse event reporting and information management
system designed for the global collection, assessment, reporting,
and analysis of clinical trial and post-marketing adverse events.
Michael O’Brien, Beardsworth’s President & CEO states, “We
are happy to incorporate OmniComm’s AE Reporting System to broaden
our ability in safety reporting, which is an essential element in
the services to our clients.” The robust functionality within
AE Reporting will automate many of the complex activities
associated with drug safety, including data entry, medical review,
reporting and case distribution.
“We are extremely pleased that Beardsworth has selected AE
Reporting to be part of its global safety surveillance practice,”
commented Stephen Johnson, President & COO of OmniComm Systems,
Inc. “We are committed to providing leading solutions and
services across the eClinical spectrum to aid our clients with
their complex clinical research needs.” Last year Beardsworth
implemented OmniComm’s TrialMaster EDC solution for capturing and
processing clinical trial data. AE Reporting will be
integrated with TrialMaster, to fully automate the safety handling
process from the initial capture of the AE to the submission to the
FDA and other regulatory authorities.
About BeardsworthBeardsworth Consulting Group, Inc. (www.beardsworth.com) is a
full-service CRO whose service offerings span all stages of drug
development and clinical trial management. With a command of the
complex trial, Bea
‘/>”/>
